… poor bioavailability. Thus, improving the water-solubility and bioavailability of curcumin are
… to overcome low bioavailability of curcumin is the formulation of curcumin into nanoscale …

… great promises for … Bioavailability The oral bioavailability of curcumin is poor, which limits
its pharmacological efficacy in vivo [60]. Yang et al. reported that the bioavailability of curcumin …

… The antitoxic potential of curcumin against various toxin like Aflatoxin B1 is reported. Although
curcumin is a safe and promising phytochemical, it suffers from bioavailability problems …

… activities rather than curcumin itself (12,13). In view of the very low bioavailability of curcumin
as … be taken into consideration when evaluating the activity of curcumin in various diseases. …

… In addition, to overcome the problems related to pharmacokinetic limitations and improve
the bioavailability of curcumin, the latter was encapsulated in polylactic-co-glycolic NPs (…

Curcumin (CUR) is a yellow-coloured polyphenolic compound obtained from the rhizomes
of Curcuma longa. In-depth pharmacological screening of curcumin has given the evidence …

… solubility and low bioavailability of curcumin in the human … curcumin formulations using
nanotechnology delivery systems have brought new strategies to deliver and maximize curcumin …

… Notably, thanks to the recent advances in the formulation of different bioavailable curcumin
preparations, the main drawback of this compound—the same poor absorption—appears to …

… Nanoencapsulation shows significant promise for food and healthcare products due to its
ability to enhance bioavailability, reduce the required dosage of toxic and expensive bioactive …

… In conclusion, the overall experimental evidence suggests that curcumin-based NP formulations
hold great promise in cancer therapeutics as anticancer chemotherapeutic agents that …